1. Metformin Regulating miR-34a Pathway to Inhibit Egr1 in Rat Mesangial Cells Cultured with High Glucose
   Can Wu et al, 2018, International Journal of Endocrinology CrossRef
2. Epigenetic effects of metformin: From molecular mechanisms to clinical implications
   Stephanie Claire Bridgeman et al, 2018, Diabetes, Obesity and Metabolism CrossRef
3. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
   Yi-Jie Li et al, 2024, World Journal of Gastroenterology CrossRef
4. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
   Paola Dongiovanni et al, 2018, International Journal of Molecular Sciences CrossRef
5. To die or not to die: death signaling in nonalcoholic fatty liver disease
   Yuko Akazawa et al, 2018, Journal of Gastroenterology CrossRef
6. Identification and characterization of metformin on peptidomic profiling in human visceral adipocytes
   Yao Gao et al, 2018, Journal of Cellular Biochemistry CrossRef
7. Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts
   Yang Shen et al, 2016, International Journal of Molecular Sciences CrossRef
8. Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
   Chengyuan Liang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
9. TAM 2.0: tool for MicroRNA set analysis
   Jianwei Li et al, 2018, Nucleic Acids Research CrossRef
10. Endothelin-1 promotes epithelial-mesenchymal transition in human chondrosarcoma cells by repressing miR-300
    Min-Huan Wu et al, 2016, Oncotarget CrossRef
11. Metformin and insulin-resistant related diseases: Emphasis on the role of microRNAs
    Nahid Alimoradi et al, 2021, Biomedicine & Pharmacotherapy CrossRef
12. Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights
    Kristen Stephenson et al, 2018, Gene Expression CrossRef
13. Role of microRNAs in the process of metformin treating multiple diseases
    Ningning Ma et al, 2021, Frigid Zone Medicine CrossRef
14. Advances in metformin for the treatment of non-alcoholic fatty liver disease in children
    Qian-Long Wu et al, 2022, Expert Review of Gastroenterology & Hepatology CrossRef
15. DJ-1 deficiency alleviates steatosis in cultured hepatocytes
    Harmesh N. Chaudhari et al, 2015, Biotechnology and Bioprocess Engineering CrossRef
16. Metformin-induced suppression of Nemo-like kinase improves erythropoiesis in preclinical models of Diamond–Blackfan anemia through induction of miR-26a
    Mark C. Wilkes et al, 2020, Experimental Hematology CrossRef
17. MicroRNAs and Nonalcoholic Steatohepatitis: A Review
    Asahiro Morishita et al, 2023, International Journal of Molecular Sciences CrossRef
18. Metformin downregulates miR223 expression in insulin-resistant 3T3L1 cells and human diabetic adipose tissue
    Yousof Naghiaee et al, 2020, Endocrine CrossRef
19. Metformin inhibits high glucose‐induced mesangial cell proliferation, inflammation and ECM expression through the SIRT1‐FOXO1‐autophagy axis
    Jiang Xu et al, 2019, Clinical and Experimental Pharmacology and Physiology CrossRef
20. Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model
    Hualin Wang et al, 2017, BioMed Research International CrossRef
21. Mechanism of the Hypoglycemic Activity and Hepatoprotective Effect of the Aqueous Extract of Cecropia obtusifolia Bertol
    María de los Ángeles Fortis-Barrera et al, 2020, Journal of Medicinal Food CrossRef
22. Mechanism of gemcitabine-induced suppression of human cholangiocellular carcinoma cell growth
    YUKA TOYOTA et al, 2015, International Journal of Oncology CrossRef
23. Research progress of metformin in the treatment of liver fibrosis
    Anqi Zhang et al, 2023, International Immunopharmacology CrossRef
24. Novel roles for LIX1L in promoting cancer cell proliferation through ROS1-mediated LIX1L phosphorylation
    Satoki Nakamura et al, 2015, Scientific Reports CrossRef
25. Role of MicroRNAs in NAFLD/NASH
    Gyongyi Szabo et al, 2016, Digestive Diseases and Sciences CrossRef
26. Metformin attenuates ischemia/reperfusion-induced apoptosis of cardiac cells by downregulation of p53/microRNA-34a via activation of SIRT1
    Weiwei Li et al, 2021, Canadian Journal of Physiology and Pharmacology CrossRef
27. Adipocyte alterations in endometriosis: reduced numbers of stem cells and microRNA induced alterations in adipocyte metabolic gene expression
    Masoumeh Majidi Zolbin et al, 2019, Reproductive Biology and Endocrinology CrossRef
28. MicroRNA‐223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes
    Yong He et al, 2019, Hepatology CrossRef
29. Autophagy-regulating miRNAs: potential targets for obesity and related metabolic disorders
    Tian Zhang et al, 2021, Drug Discovery Today CrossRef
30. Who watches the watchmen? Regulation of the expression and activity of sirtuins
    Marcin Buler et al, 2016, The FASEB Journal CrossRef
31. Tenascin-X is increased with decreased expression of miR-378a-5p and miR-486-5p in mice fed a methionine-choline-deficient diet that induces hepatic fibrosis
    Ken-ichi MATSUMOTO et al, 2024, Biomedical Research CrossRef
32. Metformin: update on mechanisms of action on liver diseases
    Gaoyi Ruan et al, 2023, Frontiers in Nutrition CrossRef
33. An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present
    Ans Jacobs et al, 2016, Current Protocols in Mouse Biology CrossRef
34. Comparing the effect of cinnamaldehyde and metformin on expression of MiR320 and MiR26-b in insulin resistant 3T3L1 adipocytes
    Yousof Naghiaee et al, 2021, Phytomedicine Plus CrossRef
35. Hepatic miR-363 promotes nonalcoholic fatty liver disease by suppressing INSIG1
    Lechen Wang et al, 2024, The Journal of Nutritional Biochemistry CrossRef
36. Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis
    Kana Matsumoto et al, 2022, Molecular Medicine Reports CrossRef
37. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
    Tomoko Tadokoro et al, 2021, International Journal of Molecular Sciences CrossRef
38. Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention
    Ana Luz Tobaruela-Resola et al, 2024, Nutrients CrossRef
39. Descending Expression of miR320 in Insulin-Resistant Adipocytes Treated with Ascending Concentrations of Metformin
    Yousof Naghiaee et al, 2020, Biochemical Genetics CrossRef
40. Metformin promotes proliferation and suppresses apoptosis in Ox-LDL stimulated macrophages by regulating the miR-34a/Bcl2 axis
    Liuliu Feng et al, 2019, RSC Advances CrossRef